Your browser doesn't support javascript.
loading
Comparative effectiveness of ustekinumab or vedolizumab after one year in 130 patients with anti-TNF-refractory Crohn's disease.
Townsend, Tristan; Razanskaite, Violeta; Dodd, Susanna; Storey, Daniel; Michail, Stephanie; Morgan, James; Davies, Michael; Penman, Douglas; Watters, Christopher; Swaminathan, Mira; Sabine, Joseph; Chapman, Adam; Smith, Philip J; Flanagan, Paul K; Reilly, Ian; Bodger, Keith; Subramanian, Sreedhar.
Afiliação
  • Townsend T; Department of Gastroenterology, Royal Liverpool University Hospital, Liverpool, UK.
  • Razanskaite V; Department of Gastroenterology, University Hospital Aintree, Liverpool, UK.
  • Dodd S; Department of Biostatistics, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
  • Storey D; Department of Gastroenterology, Royal Liverpool University Hospital, Liverpool, UK.
  • Michail S; Department of Gastroenterology, Royal Liverpool University Hospital, Liverpool, UK.
  • Morgan J; Department of Gastroenterology, Royal Liverpool University Hospital, Liverpool, UK.
  • Davies M; Department of Gastroenterology, Royal Liverpool University Hospital, Liverpool, UK.
  • Penman D; Department of Gastroenterology, Wirral University Teaching Hospital, Wirral, UK.
  • Watters C; Department of Gastroenterology, Wirral University Teaching Hospital, Wirral, UK.
  • Swaminathan M; Department of Gastroenterology, Countess of Chester Hospital, Chester, UK.
  • Sabine J; Department of Gastroenterology, Wirral University Teaching Hospital, Wirral, UK.
  • Chapman A; Department of Gastroenterology, University Hospital Aintree, Liverpool, UK.
  • Smith PJ; Department of Gastroenterology, Royal Liverpool University Hospital, Liverpool, UK.
  • Flanagan PK; Department of Gastroenterology, Wirral University Teaching Hospital, Wirral, UK.
  • Reilly I; Department of Gastroenterology, Countess of Chester Hospital, Chester, UK.
  • Bodger K; Department of Biostatistics, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
  • Subramanian S; Department of Gastroenterology, Royal Liverpool University Hospital, Liverpool, UK.
Aliment Pharmacol Ther ; 52(8): 1341-1352, 2020 10.
Article em En | MEDLINE | ID: mdl-32955122
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Crohn / Anticorpos Monoclonais Humanizados / Ustekinumab Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Aliment Pharmacol Ther Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Crohn / Anticorpos Monoclonais Humanizados / Ustekinumab Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Aliment Pharmacol Ther Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido